{"id":"W2154948351","doi":"10.1200/jco.2003.06.099","title":"Gemcitabine Plus Vinorelbine Compared With Cisplatin Plus Vinorelbine or Cisplatin Plus Gemcitabine for Advanced Non–Small-Cell Lung Cancer: A Phase III Trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group","year":2003,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":245,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Vinorelbine; Medicine; Gemcitabine; Internal medicine; Lung cancer; Cisplatin; Hazard ratio; Oncology; Chemotherapy; Cancer; Ototoxicity; Confidence interval","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.008695245,0.0004156136,0.004432579,0.0001483532,0.0002175762,0.0000169745,0.0003704807,0.0003645746,0.0001445388],"category_scores_gemma":[0.01318633,0.0001999622,0.0007563995,0.0004998442,0.001221616,0.0001761275,0.00007759123,0.0009439896,2.06914e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001287219,"about_ca_system_score_gemma":0.03852444,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01329637,"about_ca_topic_score_gemma":0.1146238,"domain_scores_codex":[0.9904595,0.001254,0.006438795,0.0004517302,0.0009573686,0.0004385912],"domain_scores_gemma":[0.9819936,0.008372605,0.007163879,0.0003507264,0.001521664,0.0005975136],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.915876,0.004775676,0.01444316,0.0007781779,0.008402985,0.0001691477,0.001190584,0.01001213,0.0006961839,0.001747149,0.02706055,0.01484823],"study_design_scores_gemma":[0.9321769,0.01555582,0.004896937,0.0008825613,0.007670435,0.0001291581,0.0005240659,0.008075931,0.0003279492,0.0001579489,0.02925058,0.000351639],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.979955,0.001223824,0.0006266955,0.008592322,0.003975598,0.004498267,0.0004201788,0.000007723353,0.0007003593],"genre_scores_gemma":[0.9879938,0.0009658096,0.005588133,0.001945628,0.001416293,0.0003783195,0.00004237795,0.00004976396,0.001619911],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1013274,"threshold_uncertainty_score":0.995126,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.134450896684909,"score_gpt":0.4988893839233714,"score_spread":0.3644384872384624,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}